Can a simple blood test guide cancer treatment? new study investigates.

NCT ID NCT05032092

Ongoing Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether analyzing the genes of a tumor (from a tissue sample or a blood test) can help doctors pick a more effective treatment for people with advanced solid cancers that have stopped responding to standard therapies. About 235 participants will have their tumor DNA tested, and researchers will track how long their next treatment keeps the cancer from growing compared to their previous therapy. The goal is to see if this personalized approach improves outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma metastatic malignant neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED CARCINOMA METASTATIC CANCER

Contacts and locations

Locations

Landesklinikum Amstetten

Amstetten, 3300, Austria
Landeskrankenhaus Feldkirch, Department of Internal Medicine II

Feldkirch, Vorarlberg, 6807, Austria
Medical University of Graz

Graz, 8036, Austria
Medical University of Innsbruck, Department of Hematology and Oncology

Innsbruck, Tyrol, 6020, Austria
Ordensklinikum Linz

Linz, Upper Austria, 4010, Austria
University Hospital Salzburg, Department of Internal Medicine III

Salzburg, State of Salzburg, 5020, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.